162 related articles for article (PubMed ID: 2347548)
1. The ursodeoxycholate dose-dependent formation of ursodeoxycholate-glucuronide in the rat and the choleretic potencies.
Takikawa H; Sano N; Narita T; Yamanaka M
Hepatology; 1990 May; 11(5):743-9. PubMed ID: 2347548
[TBL] [Abstract][Full Text] [Related]
2. Effects of ursodeoxycholate, its glucuronide and disulfate and beta-muricholate on biliary bicarbonate concentration and biliary lipid excretion.
Takikawa H; Sano N; Minagawa K; Yamanaka M
J Hepatol; 1992 May; 15(1-2):77-84. PubMed ID: 1506660
[TBL] [Abstract][Full Text] [Related]
3. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Na+/H+ exchange in the rat is associated with decreased ursodeoxycholate hypercholeresis, decreased secretion of unconjugated urodeoxycholate, and increased ursodeoxycholate glucuronidation.
Lake JR; Renner EL; Scharschmidt BF; Cragoe EJ; Hagey LR; Lambert KJ; Gurantz D; Hofmann AF
Gastroenterology; 1988 Aug; 95(2):454-63. PubMed ID: 2455672
[TBL] [Abstract][Full Text] [Related]
5. Hypercholeresis induced by unconjugated bile acid infusion correlates with recovery in bile of unconjugated bile acids.
Gurantz D; Schteingart CD; Hagey LR; Steinbach JH; Grotmol T; Hofmann AF
Hepatology; 1991 Mar; 13(3):540-50. PubMed ID: 1999323
[TBL] [Abstract][Full Text] [Related]
6. Bile secretory characteristics of beta-muricholate and its taurine conjugate are similar to those of ursodeoxycholate in the rat.
Kanai S; Kitani K; Sato Y
Life Sci; 1991; 48(10):949-57. PubMed ID: 2000026
[TBL] [Abstract][Full Text] [Related]
7. Effect of protoporphyrin IX on ursodeoxycholate-induced hypercholeresis in the rat.
Garcia-Marin JJ; Redondo-Torres JG; Perez-Barriocanal F; Berenson MM
Clin Sci (Lond); 1988 Dec; 75(6):593-9. PubMed ID: 3208492
[TBL] [Abstract][Full Text] [Related]
8. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
Sano N; Takikawa H; Yamanaka M
J Hepatol; 1993 Feb; 17(2):241-6. PubMed ID: 8445238
[TBL] [Abstract][Full Text] [Related]
9. Influence of backward perfusion on ursodeoxycholate-induced choleresis in isolated in situ rat liver.
Perez Barriocanal F; Marin JJ; Dumont M; Erlinger S
J Hepatol; 1990 Sep; 11(2):165-71. PubMed ID: 2254627
[TBL] [Abstract][Full Text] [Related]
10. Effects of ursodeoxycholate on maximal biliary secretion of bilirubin in the rat.
Galan AI; Jimenez R; Muñoz ME; Gonzalez J
Biochem Pharmacol; 1990 Apr; 39(7):1175-80. PubMed ID: 2108685
[TBL] [Abstract][Full Text] [Related]
11. The bile flow and biliary excretion of ursocholate in the rat.
Kitani K; Kanai S; Sato Y; Uchida K
Life Sci; 1983 Dec; 33(24):2377-86. PubMed ID: 6645805
[TBL] [Abstract][Full Text] [Related]
12. Difference in the effects of ursodeoxycholate and its taurine conjugate on the biliary excretion of sulfobromophthalein in the rat.
Kanai S; Kitani K; Sato Y
J Hepatol; 1990 Mar; 10(2):174-9. PubMed ID: 2332588
[TBL] [Abstract][Full Text] [Related]
13. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
[TBL] [Abstract][Full Text] [Related]
14. Hepatic biotransformation and choleretic effect of 7-ketolithocholic acid in the rat.
Kanai S; Sato Y; Nokubo M; Kitani K
Lipids; 1989 Oct; 24(10):859-65. PubMed ID: 2811609
[TBL] [Abstract][Full Text] [Related]
15. Role of H+ transport in ursodeoxycholate-induced biliary HCO-3 secretion in the rat.
Garcia-Marin JJ; Corbic M; Dumont M; de Couët G; Erlinger S
Am J Physiol; 1985 Sep; 249(3 Pt 1):G335-41. PubMed ID: 2994491
[TBL] [Abstract][Full Text] [Related]
16. Effects of sodium ursodeoxycholate, hyodeoxycholate and dehydrocholate on cholesterol and bile acid metabolism in rats.
Uchida K; Nomura Y; Kadowaki M; Arisue K; Takeuchi N; Ishikawa Y
J Pharmacobiodyn; 1983 May; 6(5):346-57. PubMed ID: 6620121
[TBL] [Abstract][Full Text] [Related]
17. Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit.
Cohen BI; Hofmann AF; Mosbach EH; Stenger RJ; Rothschild MA; Hagey LR; Yoon YB
Gastroenterology; 1986 Jul; 91(1):189-97. PubMed ID: 3710068
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors.
Renner EL; Lake JR; Cragoe EJ; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1988 Feb; 254(2 Pt 1):G232-41. PubMed ID: 2831731
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholate-induced hypercholeresis in cirrhotic rats: further evidence for cholehepatic shunting.
Elsing C; Sägesser H; Reichen J
Hepatology; 1994 Oct; 20(4 Pt 1):1048-54. PubMed ID: 7927207
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation of bile acids by their high-dose infusion into rats.
Takikawa H; Narita T; Sano N; Yamanaka M
Hepatology; 1991 Jun; 13(6):1222-8. PubMed ID: 2050336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
